Debt-to-equity in % of PAVmed Inc. from Q3 2017 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
PAVmed Inc. quarterly Debt-to-equity history and change rate from Q3 2017 to Q3 2025.
  • PAVmed Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 66%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

PAVmed Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 66% +172% 30 Sep 2025
Q2 2025 136% +232% 30 Jun 2025
Q1 2025 -406% -291% -253% 31 Mar 2025
Q4 2024 -129% +20% +13.3% 31 Dec 2024
Q3 2024 -106% +91% +46.4% 30 Sep 2024
Q2 2024 -96% +265% +73.3% 30 Jun 2024
Q1 2024 -115% +22359% +99.5% 31 Mar 2024
Q4 2023 -149% -368% -168% 31 Dec 2023
Q3 2023 -197% -278% -343% 30 Sep 2023
Q2 2023 -361% -407% -881% 30 Jun 2023
Q1 2023 -22474% -22495% -103652% 31 Mar 2023
Q4 2022 220% +207% +1640% 31 Dec 2022
Q3 2022 81% +53% +187% 30 Sep 2022
Q2 2022 46% -20% -29.9% 30 Jun 2022
Q1 2022 22% -231% -91.4% 31 Mar 2022
Q4 2021 13% +263% 31 Dec 2021
Q3 2021 28% +226% 30 Sep 2021
Q2 2021 66% +274% 30 Jun 2021
Q1 2021 252% +495% 31 Mar 2021
Q4 2020 -251% +46% +15.5% 31 Dec 2020
Q3 2020 -198% +131% +39.8% 30 Sep 2020
Q2 2020 -208% +426% +67.2% 30 Jun 2020
Q1 2020 -243% -1509% -119% 31 Mar 2020
Q4 2019 -297% -603% -197% 31 Dec 2019
Q3 2019 -329% -571% -236% 30 Sep 2019
Q2 2019 -634% +504% +44.3% 30 Jun 2019
Q1 2019 1267% +1432% 31 Mar 2019
Q4 2018 306% +440% 31 Dec 2018
Q3 2018 243% +377% 30 Sep 2018
Q2 2018 -1139% 30 Jun 2018
Q1 2018 -165% 31 Mar 2018
Q4 2017 -134% 31 Dec 2017
Q3 2017 -135% 30 Sep 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.